Latest Breaking News On - Jianxin duan - Page 1 : comparemela.com

Press release content from PR Newswire. The AP news staff was not involved in its creation. OBI Pharma Announces Poster Presentations at AACR 2021 Annual Meeting for OBI-3424, OBI-998, Globo H and SSEA-4 April 6, 2021 GMT TAIPEI, Taiwan, April 6, 2021 /PRNewswire/ OBI Pharma, Inc. (TPEx: 4174) today announced the data highlighting the characteristics and antitumor efficacy of OBI-3424 and animal studies of OBI-998, as well as the T-cell inhibitory roles of Globo-H and SSEA-4 in the tumor microenvironment, will be presented at the American Association of Cancer Research (AACR) Virtual Annual Meeting from April 10–15, 2021. OBI’s Chief Scientific Officer, Ming-Tain Lai, Ph. D stated that “OBI Pharma is proud to present at the AACR Annual Meeting our latest findings on our Cancer portfolio products, OBI-3424 and OBI-998. OBI-3424′s impressive anti-AKR1C3 tumor activities in various cancer models, and enhanced efficacy when used in combination with standard-of-care chemothe

T ai peiUnited statesTzu chiuRen yu hsuHsin yi tungJianxin duanDonald jungKevin poulosYueh chin wuChin chan leeTianyang qiHui wen changChung chen suJiann shiun laiAdagloxad simoleninChun chung wang